发明人杨光,陈志强,沈红梅. "一种复瑞替尼杂质13的合成方法" [P]. 中国发明专利, 专利号 CN 115450823 A, 授权公告日 2016-05-09.
发明人郭海燕,唐晓军,赵玉洁. "Method for the Synthesis of Foritinib Impurity 13" [P]. 中国发明专利, 专利号 CN 110289821 A, 授权公告日 2017-12-19.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 复瑞替尼杂质13 in Pharmaceutical Formulations". Chemosphere, 2013, 429, 737-749.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 复瑞替尼杂质13 as an Impurity". Molecules, 2022, 2154, (4), 9505-9528.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Foritinib Impurity 13 Using HRMS and NMR". Chromatographia, 2010, 1386, (5), 387-390.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 复瑞替尼杂质13 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2017, 1079, (3), 3453-3479.